The fetus is an allograft foreign to the mother by the hemizygous set of paternal alleles. In a randomly mating population the mother may be incompatible with the fetus at any locus and the chance of incompatibility is increased according to the number of alleles at that locus.
The persistence of the normal human fetal allograft is a puzzle that continues to intrigue biologists. The immunobiology of the trophoblast was debated at length at a symposium held in Cambridge in 1973. In a preface to the proceedings the editors (Edwards, et al, 1975 ) ventured their personal opinion that 'the properties of the trophoblast as a natural filter currently offer the most critical single explanation for fetal survival'. To search for a single explanation of such complex biological interactions as those involved in the fetomaternal relationship is perhaps rather ambitious. The problem of the persistence of trophoblast-natural, invasive, or malignant-must be regarded as a sequel of maternal conditioning to the normal products of conception. This may affect her role as host to any supervening malignantly transformed trophoblast.
Major Histocompatibility Systems THE HLA SYSTEM It is probable that each species has a major histocompatibility complex and in man this is called HLA. It is a system with a high degree of polymorphism with a wide tissue distribution of some of the antigenic determinants and a more limited expression of others. There are four loci with polymorphic variants identifiable in Caucasians: A(12), B(17), C(5) and D(6). The specificities given in table I are designated according to the WHO-Luis terminology (Histocompatibility Testing, 1975) . The A, B and C locus antigens are detected serologically by a microcytotoxicity test on lymphocytes. The D locus antigens are detected by the mixed lymphocyte culture method using homozygous cells from donors of known D locus types as standard stimulating cells. The A, B and C locus antigens are expressed on both T and B lymphocytes, the D locus antigens are certainly present on B lymphocytes but the situation with regard to their presence on T lymphocytes is unresolved. The next histocompatibility workshop, the seventh, is to be concerned with the detection of determinants specific for B lymphocytes that are absent from T lymphocytes. These are envisaged as the human homologue of the La specificities described in other species (Sachs and Cone, 1973) .
The major histocompatibility complex is inherited as a genetic unit, the haplotype. Recombination of about 1 % is known to occur between the A and B loci and it is likely to occur with the same order of frequency at the other loci. The position of the loci on the chromosome is in the alignment A, C, B, D.
THE ABO BLOOD GROUP SYSTEM
In the context of histocompatibility the role of the ABO system must also be considered even though its role in tissue transplantation appears to be subordinate to that of the HLA system.
Histocompatibility and Reproduction
Consideration will now be given to the relevance of the HLA and ABO systems in the processes preceding the possibility of persistence of trophoblast, namely, properties of gametes, fertilization, and the maintenance and termination of pregnancies.
FERTILITY
The products of the main histocompatibility systems in man are expressed on spermatozoa. Haploid expression of HLA antigens of the A and B loci has been demonstrated by Fellous and Dausset (1970) , and later Halim et al (1975) showed that the haplotype was expressed on the heads of the spermatozoa. Levis et al (1974) showed that human spermatozoa stimulated allogeneic lymphocytes in culture and suggested the use of this method in one-way mixed lymphocyte culture tests. The value of the technique has been confirmed by Halim and Festenstein (1975) who have demonstrated the haploid expression of D locus antigens on spermatozoa.
These observations present a mechanism for the selection of spermatozoa for fertilization through 132 A29  AW23  AW25  AW30  Locus A   Al, A2, A3,   AW24   AIO   A1 A, A28, AWI9   AW24~AW26  ;ZZZAW3l1  AW32   BW38  B5, B7, B8, B12, B13, B14, B18, BW15, BW16  BW17   Locus B  BW39  BW21, BW22, B27, BW35, BW37, BW40, BW41   Locus C  CWI, CW2, CW3, CW4, CW5 Locus D DWI, DW2, DW3, DW4, DW5, DW6. Lauritsen et al (1975) have concluded that ABO incompatibility between mother and fetus is likely to be a cause ofearly abortions, but almost exclusively when the fetus has normal chromosomes.
HLA Antibodies and Pregnancy
In an ABO incompatible pregnancy maternal antibody against fetal red cells is preformed. The effect of the pregnancy is to alter the character of the antibody which is part of the process which may culminate in haemolytic disease of the newborn due to antibodies of the ABO system. The important biological interaction of the ABO and Rhesus system is a model of interplay between different genetic systems (Levine, 1943 (Bodmer, 1973 (Lawler, 1973 The patient's serum contained anti-B27 antibody which would not have been produced as a result of immunization by either of the children because neither had inherited the appropriate haplotype from the father. The presence of theanti-B27 antibody could be accounted for by another conceptus following the birth of the youngest male or by the persistence of trophoblast from the pregnancy with the hydatidiform mole between the liveborn children.
It is known that in rare instances choriocarcinoma may occur many years after the last possible pregnancy, for example, in a hysterectomized patient (Lawler et al, 1976) . In this context it is interesting to note the possible relevance of the persistence of trophoblast from a previous pregnancy in the aetiology of spina bifida and anencephaly (Knox, 1974; Clarke et al, 1975) .
HLA Antigens and Trophoblastic Disease
Evidence of associations between various diseases of the HLA system continues to accumulate and several groups of workers have looked for effects related to trophoblastic disease (Ivaskova' et al, 1968; Amiel and Lebovici, 1970; Rudolph and Thomas, 1970; Lawler et al, 1971; Lewis and Terasaki, 1971; Mogensen and Kissmeyer-Nielsen, 1972; Mittal et al, 1975 The first question which can be asked is whether patients with trophoblastic disease show any disturbance in the distribution of HLA antigens. In a study of 100 cases, 51 of choriocarcinoma and 49 of 'treated moles ', typed between 1969 ', typed between and 1972 ', typed between , Klouda (1975 found no statistically significant difference from the frequency found in normal controls of the antigens in the patients nor in 93 of their husbands who were available for testing.
The fact that the frequencies of the HLA A and B locus antigens in the patients and their husbands do not differ significantly from that found in normal controls does not preclude the possibility that certain antigenic combinations between husband and wife might constitute a risk factor to the patient. If this were the case one would expect to find that the matings were not random. In a study of HLA mating analysed separately for the A and B locus antigens the frequency of the different mating types was found to be as expected on the basis of the antigenic frequencies actually observed in the patients and their husbands (Klouda et al, 1972) . Thus, as far as these antigens are concerned, mating was at random. The risk of a woman getting trophoblastic disease is apparently not influenced by her choice of mate as far as the HLA antigens are concerned.
Another way of looking at the problem is to see whether there is a tendency for the patients to be more or less compatibly mated than normal control couples. It has been shown that HLA incompatibility scores between husbands and patients with trophoblastic diseases do not differ significantly from those of controls . Furthermore an analysis of the different clinical groups also revealed no difference between them as far as A and B locus incompatibility was concerned (Klouda, 1975) .
Because of the isogenicity of tumour and child the patients in whom the question of genetic effects can be most closely studied are those in whom choriocarcinoma followed live term birth. A child can be incompatible with the mother for one A locus allele and one B locus allele. In the majority of cases scoring for incompatibilities is straightforward. However, difficulties arise when all the specificities cannot be defined. When the child inherits the haplotype with an undefined specificity from the father, and the mother also has only one allele defined at that locus, if the mother were homozygous the child would be incompatible (scored (+) The ABO System and Trophoblastic Disease
In marked contrast to the absence of effect with the HLA system is the relationship to the ABO system. It has been shown that in a Caucasian population an increased risk of choriocarcinoma for group A women, as compared with group 0, is dependent on the ABO group of the husband. The relative risk for group A women with group 0 husbands as compared with group A with group A husbands was 10 4/1 . Recently, Bagshawe (1976) has extended the analysis and found that the risk of group 0 women developing a choriocarcinoma also relates to the group of the husband, greater risk being associated with group A husbands. The observations up to this point could be explained by immunological reaction involving fetal recognition of the maternal tissue as foreign. Difficulties arise, however, when the ABO groups of the children antecedent to the choriocarcinoma are studied. In both the high risk mating types female A x male 0 and female 0 x male A the segregation of the children was not disturbed so there was no tendency to produce only offspring with a phenotype incompatible to the mother (Bagshawe, 1976) . This means that the risk depends not on the genotype of the child isogenic with the tumour but on the phenotype of the spouse.
As has been pointed out already, the evidence based on immunization to HLA antigens favours the contention of isogenicity of host and tumour when choriocarcinoma follows live term birth. It is difficult to explain an effect dependent on nonrandom mating that is not related to the genotype of the child at the relevant locus. An explanation may have to be sought very early, possibly at fertilization, where products carried by or accompanying the sperm that fuses with the oocyte have some influence on future trophoblastic development.
The idea of non-Mendelian transmission of genetic information into the nuclei of cells in the female genital tract is a possibility that might be considered in this context. The rapid disappearance of excess spermatozoa in the female has been attributed to phagocytosis and subsequent drainage through the cervix (Yanagimachi and Chang, 1963) . On the other hand, Reid (1965) showed that stromal cells regenerating after injury to the mouse uterine mucosa took up radioactively labelled spermatozoa, sometimes with the spermatozoa enveloped in a fold of the stromal nucleus. So the possibility of the total genotype of the male being effective through some mechanism involving an intranuclear event between sperm and female genital tract cells cannot be excluded.
Cellular Reaction
It has been suggested that the infiltration of mononuclear cells in gestational choriocarcinoma is a response to tumour antigens (Elston and Bagshawe, 1973) . Such a reaction could also reflect the histocompatibility differences between tumour and host, since the evidence presented in this paper favours the idea that trophoblastic tumours express HLA specificities. Elston and Bagshawe (1973) (Lawler et al, 1975) . A failure of mononuclear infiltration round a choriocarcinoma to be associated with a good prognosis could be due to the inhibition of mitotic activity of host cells in the presence of viable tumour cells. These factors, which may be regarded as a carry-over of normal biological effect, could be reinforced if the patient's immune responses are also generally depressed.
Conclusions
The HLA system has given an insight into the general question of the immunogenic activity of trophoblast. Evidence that a single pregnancy with a hydatidiform mole can provoke HLA antibody formation suggests that trophoblastic cells or their products are immunizing agents which could also be operative in normal pregnancies. As far as choriocarcinoma is concerned there is no clear-cut evidence to impute a role to the HLA system amongst the risk factors. The choice of mate in relation to the HLA system appears not to influence a woman's chance of developing a choriocarcinoma. However, a detailed analysis of the system amongst the different clinical groups has yet to be made when the number of cases studied is sufficient. Another factor which must be considered is whether there is any difference in prognosis for responders and nonresponders as defined by a capacity to make HLA antibodies is concerned. The D locus factors also present an area for further study, but the genetic disequilibrium in the HLA system decreases the chance of finding genetic associations with D locus factors if none have been shown with studies restricted to the A and B loci. Furthermore, the response of the patient in the mixed lymphocyte culture test in relation to her offspring is influenced by the immunological effects of pregnancy.
The ABO system also presents a fruitful area for further study of risk and prognostic factors in choriocarcinoma. It would be of interest to have data on secretor status. The relevance of the Atri system (Marcelli-Barge et al, 1975) might also be considered since this is an antigen expressed on the lymphocytes of 5% of group A ABH secretors. Since risk factors depend on the phenotype of the male and not the genotype of the conceptus conSylvia D. Lawler sideration might be given to the possibility of an effect mediated by integration of nuclear elements in the sperm with female genital tract cells.
The most interesting question still remains unanswered: What makes the trophoblast become malignant? This problem could be approached by attempting to define differences between choriocarcinoma supervening after molar or non-molar pregnancies and by ascertaining which molar pregnancies have a malignant potential.
